HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?

    loading  Checking for direct PDF access through Ovid

Abstract

We describe the first case of a patient presenting Kaposi's sarcoma with human herpes virus 8 (HHV8) viremia after switching from a protease inhibitor to an integrase inhibitor-based combination antiretroviral therapy, followed by a rapid remission when resuming protease inhibitor. We suggest that the recent recommendations to switch all HIV patients to protease inhibitor-free regimens should be carefully re-evaluated especially in MSM HIV patients which are at higher risks of HHV8 infections and associated malignancies.

Related Topics

    loading  Loading Related Articles